Literature DB >> 15863154

Ovarian cancer incidence in the United States, 1992-1999.

Jeffrey T Quirk1, Nachimuthu Natarajan.   

Abstract

OBJECTIVE: The purpose of this epidemiological study was to report histology-specific age-adjusted ovarian cancer incidence rates that were standardized to the recently adopted year 2000 United States standard population.
METHODS: We utilized data gathered from eleven population-based cancer registries of the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute for the years 1992 through 1999. Our analyses included data on 23,484 microscopically confirmed cases of primary malignant ovarian cancer that were diagnosed in women residing in the eleven SEER registries.
RESULTS: We categorized the 117 different histologies that were diagnosed in the 23,484 ovarian cancer cases into ten major classifications. The overall age-adjusted incidence rate for all ovarian cancer cases was 16.23 cases per 100,000 women. Epithelial tumors displayed the highest age-adjusted incidence rate (15.48), followed by germ cell tumors (0.41), sex cord-stromal tumors (0.20), and all other miscellaneous ovarian tumors (0.13). Serous epithelial tumors were the most commonly observed epithelial group (6.77 cases per 100,000 women), followed by other miscellaneous epithelial tumors (3.76), mucinous epithelial tumors (2.22), endometrioid epithelial tumors (2.11), and clear cell epithelial tumors (0.64). Notable differences were observed in the age-adjusted incidence rates for White and Black women.
CONCLUSIONS: Age-adjusted incidence rates of ovarian cancer vary by histology. This is the first study to standardize histology-specific age-adjusted incidence rates of ovarian cancer to the new 2000 United States standard population.

Entities:  

Mesh:

Year:  2005        PMID: 15863154     DOI: 10.1016/j.ygyno.2005.02.007

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  58 in total

Review 1.  Comprehensive review of imaging features of sex cord-stromal tumors of the ovary.

Authors:  Sanaz Javadi; Dhakshina M Ganeshan; Corey T Jensen; Revathy B Iyer; Priya R Bhosale
Journal:  Abdom Radiol (NY)       Date:  2021-03-16

2.  Germ Cell Tumor Ovary: an Institutional Experience of Treatment and Survival Outcomes.

Authors:  Manikandan Lakshmanan; Sameer Gupta; Vijay Kumar; Naseem Akhtar; Arun Chaturvedi; Sanjeev Misra; Kavitha Jain; Sudeep Garg
Journal:  Indian J Surg Oncol       Date:  2018-04-10

3.  A rare case of postmenopausal immature teratoma with a recurrent grave course.

Authors:  Ali Babacan; Yasar Kemal Akpak; Cem Kizilaslan; Ismet Gun; Ercument Mungen; Vedat Atay
Journal:  Int J Clin Exp Med       Date:  2014-04-15

4.  Preservation of fertility in non-Peutz-Jegher syndrome-associated ovarian sex cord tumour with annular tubules.

Authors:  Kyriaki Chatziioannidou; Diomidis Botsikas; Jean-Christophe Tille; Jean Dubuisson
Journal:  BMJ Case Rep       Date:  2015-05-12

5.  FDA Approval of PARP Inhibitors and the Impact on Genetic Counseling and Genetic Testing Practices.

Authors:  Kathryn M Buchtel; Kristen J Vogel Postula; Shelly Weiss; Carmen Williams; Mario Pineda; Scott M Weissman
Journal:  J Genet Couns       Date:  2017-08-05       Impact factor: 2.537

6.  Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response.

Authors:  Yu-Li Chen; Ming-Cheng Chang; Chia-Yen Huang; Ying-Cheng Chiang; Han-Wei Lin; Chi-An Chen; Chang-Yao Hsieh; Wen-Fang Cheng
Journal:  Mol Oncol       Date:  2011-12-20       Impact factor: 6.603

Review 7.  Imaging of pediatric ovarian neoplasms.

Authors:  Monica Epelman; Kudakwashe R Chikwava; Nancy Chauvin; Sabah Servaes
Journal:  Pediatr Radiol       Date:  2011-05-13

8.  Clinical and pathologic features of patients with non-epithelial ovarian cancer: retrospective analysis of a single institution 15-year experience.

Authors:  E Kempf; G Desamericq; B Vieites; I Diaz-Padilla; E Calvo; P Estevez; A Garcia-Arreza; M A Martinez-Maestre; I Duran
Journal:  Clin Transl Oncol       Date:  2016-05-18       Impact factor: 3.405

Review 9.  Systematic review and meta-analysis of ovarian cancers: estimation of microsatellite-high frequency and characterization of mismatch repair deficient tumor histology.

Authors:  Tuya Pal; Jenny Permuth-Wey; Ambuj Kumar; Thomas A Sellers
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

10.  Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature.

Authors:  Digant Gupta; Christopher G Lis
Journal:  J Ovarian Res       Date:  2009-10-09       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.